USD 1.26 billion
Sustained Release Excipients Market Size, Share, Growth Analysis, By Product(Gelatin, Polymers, Minerals, Sugars), By Route of Administration(Oral, Intramuscular, Subcutaneous, Transdermal), By Technology(Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2231 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
96
|Figures:
76
Sustained Release Excipients Market Insights
Sustained Release Excipients Market size was valued at USD 1.37 Billion in 2023 and is poised to grow from USD 1.49 Billion in 2024 to USD 2.82 Billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).
The global sustained release excipients market refers to the segment of the pharmaceutical industry that focuses on developing and producing excipients used in sustained release formulations.
Sustained release formulations are designed to release drugs gradually over an extended period, thereby improving patient compliance, reducing dosing frequency, and enhancing therapeutic outcomes. These excipients play a crucial role in controlling the release rate of drugs from dosage forms such as tablets, capsules, and patches.
The market for sustained release excipients has witnessed significant growth in recent years, driven by factors such as the increasing prevalence of chronic diseases, the growing demand for innovative drug delivery systems, and the rising adoption of controlled-release formulations by pharmaceutical companies.
Additionally, advancements in excipient technology, such as the development of novel polymers and coatings, have expanded the range of options available to formulators, further driving market growth. Key players in the global sustained release excipients market include both multinational corporations and smaller specialty companies. These companies invest heavily in research and development to introduce new excipients with improved performance characteristics and compatibility with a wide range of active pharmaceutical ingredients (APIs).
Moreover, partnerships and collaborations between excipient manufacturers and drug developers are common in this industry, facilitating the development of customized formulations tailored to specific therapeutic needs.
Geographically, North America and Europe dominate the global sustained release excipients market, owing to the presence of a well-established pharmaceutical industry, strong regulatory frameworks, and high levels of healthcare expenditure. However, emerging markets in Asia-Pacific and Latin America are also experiencing rapid growth, driven by factors such as increasing access to healthcare, rising disposable incomes, and expanding pharmaceutical manufacturing capabilities.
Looking ahead, the sustained release excipients market is expected to continue growing as pharmaceutical companies increasingly focus on developing innovative drug delivery systems to address unmet medical needs and improve patient outcomes.
Additionally, the growing emphasis on precision medicine and personalized therapies is likely to drive demand for excipients that enable targeted and controlled drug release. Overall, the outlook for the global sustained release excipients market remains promising, with ample opportunities for growth and innovation.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Polymers
Fastest Growth
Sugars
Growth Rate
8.4% CAGR
Global Sustained Release Excipients Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Sustained Release Excipients Market Segmental Analysis
Global Sustained Release Excipients Market is segmented by Product, By Technology, By Route Of Administration and Region. Based on Product, the market can be segmented into Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan. Based on Technology, the market is segmented into Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation, Others. Based on Route Of Administration, the market is segmented into Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Product Type
Polymers currently dominate the sustained release excipients market due to their versatility and compatibility with a wide range of pharmaceutical formulations. Polymers provide controlled drug release by forming a matrix that regulates the release of active ingredients. This adaptability makes them a preferred choice for sustained-release drug delivery systems. Moreover, the demand for long-acting and extended-release medications, especially for chronic diseases, continues to drive the use of polymers in pharmaceuticals.
However, sugars are emerging as the fastest-growing product type in the market due to the increasing awareness and interest in naturally biocompatible excipients. The growing need for patient-friendly dosage forms like taste-masking applications and orally disintegrating tablets, has boosted sugars usage as excipients due to its benefits like safety, biodegradability, and ease of processing. Sugars will maintain its title of the most rapidly growing category due to its ability to enhance drug delivery experiences and improve patient compliance.
Analysis by Technology
Targeted delivery technology currently leads the market as a result of the increasing demand for precision in drug delivery, thus allowing medications to target affected areas while minimizing side effects. Targeted delivery is highly recommended in many therapeutic applications as it improves treatment efficacy and upgrades patient comfort. Pharmaceutical companies are maintaining their position in this segment by making significant investments in R&D for targeted delivery systems.
On the other hand, Microencapsulation technology is the market’s fastest-growing segment due to its versatility in suitability for various applications. It is highly adaptive and can be employed by various industries, like food, pharmaceuticals, and cosmetics as it guarantees the controlled release of drugs, nutrients, and other bioactive compounds. Microencapsulation is growing in popularity as it provides the following benefits: protection and stabilization of sensitive substances, prolonging shelf life, and upscaling bioavailability. Thus, it is being heavily integrated into innovative drug formulations and consumer products, driving its exponential growth.
Global Sustained Release Excipients Market By Component
To get detailed analysis on other segments, Request For Free Sample Report
Sustained Release Excipients Market Regional Insights
North America dominates the market due to its thriving pharmaceutical industry, enriched by rigorous R&D, making it a global centre for drug formulation. The adoption of sustained release excipients is being driven further by a strong emphasis on patient-centric healthcare and rigid regulatory standards placed to guarantee drug efficiency and safety. The region’s position in the market is strengthened by its substantial healthcare expenditure and large presence of renowned pharmaceutical companies.
Conversely, the fastest-growing region in the sustained release excipients market is Asia-Pacific, owing its growth to increasing disposable incomes, growing population, and higher rates of chronic diseases. The apac region is seeing a rise in pharmaceutical manufacturing as it offers a skilled workforce and provides cost benefits. The demand for sustained release excipients in the region is on the rise due to this relocation of production facilities and a rising emphasis on innovative drug delivery systems.
Global Sustained Release Excipients Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Sustained Release Excipients Market Dynamics
Drivers
Growing Aging Population
- The constantly aging population is driving this market as the global demographic landscape shifts to an older age population, propelling demand for healthcare products and pharmaceuticals. Sustained release excipients provide benefits like extended drug release to improve compliance and manage chronic conditions effectively, cementing its importance producing medications that cater to the specific needs of elderly patients. As healthcare providers target the healthcare challenges associated with an aging population, this demographic shift will drive steady demand for sustained release excipients in the pharmaceutical sector.
Restraints
Regulatory Challenges
- The pharmaceutical industry is controlled by rigid regulations governing the approval and release of drugs, including those utilizing sustained release excipients, and this intricate regulatory landscape poses a major challenge. Obtaining necessary approvals after navigating these regulations while maintaining compliance can be time-consuming and expensive. Constant changes in regulatory standards and guidelines could potentially delay product development and market entry, which can stunt market growth.
Request Free Customization of this report to help us to meet your business objectives.
Sustained Release Excipients Market Competitive Landscape
The competitive landscape in the market is defined by the several companies engaged in fierce competition to gain a competitive advantage by focusing on R&D to develop new excipient formulations and delivery systems. Market players are employing strategic partnerships and acquisitions to expand their reach.
As regulatory requirements and consumer tastes evolve to align with sustainable goals, the market sees a rising demand in green and eco-friendly excipient solutions, which market participants intend to meet. This competitive environment drives innovation and product differentiation, which is a win for healthcare stakeholders as it places heavy importance on drug delivery technology developments.
Top Player’s Company Profiles
- Allergan PLC (Ireland)
- AstraZeneca (UK)
- GlaxoSmithKline PLC (UK)
- Mayne Pharma Group Limited (Australia)
- Mylan NV (US)
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- Salix Pharmaceuticals (US)
- Roche Holdings AG (Switzerland)
- Sanofi (France)
- Johnson & Johnson (US)
- Eli Lilly and Company (US)
- Merck & Co., Inc. (US)
- Teva Pharmaceutical Industries Ltd (Israel)
- AbbVie Inc. (US)
- Bristol-Myers Squibb (US)
- Gilead Sciences, Inc. (US)
- Bayer AG (Germany)
- Takeda Pharmaceutical Company Limited (Japan)
Recent Developments
-
In September 2022, Nutriventia, a company specializing in connecting global suppliers and buyers of food, health, and natural ingredients, introduced a sustained-release Prolanza ashwagandha (Withania somnifera). Prolanza represents a new-age Ashwagandha root-only extract designed to provide extended support for stress management.
-
In February 2022, Biohaven Pharmaceutical Holding Company Ltd, a clinical-stage biopharmaceutical company, and Pfizer Inc., a multinational pharmaceutical and biotechnology corporation, expressed optimism for rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist. They have recommended the 75 mg dose of rimegepant, available as an orally dissolving tablet, for marketing authorization.
Sustained Release Excipients Key Market Trends
- Increased Focus on Personalized Medicine : The growing emphasis on personalized medicine is trending in the pharmaceutical industry, including the sustained release excipients market. Advances in biomarker identification and genomics are targeting the development of medications designed according to individual patient profiles. Sustained excipients enable precise dosing and prompt timing of optimized release in therapeutic outcomes while minimizing side effects, highlighting its significance in formulation of these personalized drug delivery systems. This trend is in line with the shift towards patient-centric healthcare, driving innovation in excipient formulations and technologies.
Sustained Release Excipients Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to global sustained release excipients market analysis, the market is witnessing sustained growth due to the increasing demand for controlled-release drug formulations across the pharmaceutical industry. Pharmaceutical companies are making significant investments in sustained release excipients production to produce and deliver extended-release medications as emphasis on enhancing drug efficacy and patient compliance grows. Driven by its rigid regulatory standards, influential pharmaceutical industry, and large amount of healthcare expenditure, North America is at the top of the market as of now.
The APAC region is witnessing rapid growth fueled by higher disposable incomes, rising populations, and heightened pharmaceutical manufacturing. The competition in the market is heating up as key market players dive into R&D in order to innovate new excipient formulations and delivery systems.
In coming years, the sustained release excipients market will continue to grow due to constant innovation. Drug delivery systems will be transformed with the adoption of advanced technologies, such as nanotechnology and biodegradable excipients, providing more accurate and controlled drug release while reducing side effects.
Additionally, the industry will see heightened alliances between excipient suppliers and pharmaceutical companies to co-develop customized solutions for specific therapeutic areas and patient populations.
Sustained release excipients will be increasingly adopted in drug development as global healthcare systems adjust according to the evolving needs of patients, guaranteeing provision of safe and effective medications while aligning themselves to personalized medicine trends and global healthcare demands.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.26 billion |
| Market size value in 2031 | USD 2.60 billion |
| Growth Rate | 8.4% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Sustained Release Excipients Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Sustained Release Excipients Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Sustained Release Excipients Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Sustained Release Excipients Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Sustained Release Excipients Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Sustained Release Excipients Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
